IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 39 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 2,000 | -87.9% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 16,540 | -0.8% | 0.00% | – |
| Q2 2014 | $17,000 | 0.0% | 16,680 | 0.0% | 0.00% | – |
| Q1 2014 | $17,000 | – | 16,680 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 16,680 | 0.0% | 0.00% | – |
| Q3 2013 | $33,000 | -95.1% | 16,680 | -95.2% | 0.00% | – |
| Q2 2013 | $672,000 | – | 346,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|